ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2083

Understanding Knee Function and Symptom Management in Individuals with Risk Factors for Knee Osteoarthritis

Jason Jakiela1, Daniel White 2, Hiral Master 2, Meredith Christiansen 1, Dana Voinier 1, Lauren Neely 1 and Louise Thoma 3, 1University of Delaware, Newark, 2University of Delaware, Newark, DE, 3University of North Carolina at Chapel Hill, Newark

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: injury, obesity and physical function, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Epidemiology & Public Health Poster III: OA, Gout, & Other Diseases – ARP

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Worse knee function and frequent use of knee symptom management strategies are common in people with symptomatic knee osteoarthritis (SxOA). There are several risk factors for SxOA, with the most common being overweight/obese (OW/OB) or having a previous knee injury/surgery (KISHx). Prior to the onset of SxOA, individuals likely are not seeking care, however the presence of risk factors may help identify those experiencing signs of early knee dysfunction and need for symptom management. Therefore, the purpose of this study was to describe the association of knee OA risk factors with knee function and symptom management. We stratified by frequency of knee pain since this is strongly related to knee function and use of symptom management strategies.

Methods: We used data from the Osteoarthritis Initiative (OAI). Our analytic sample was limited to those who had at least one risk factor for knee OA and were free of SxOA at baseline. Risk factors were: OW/OB as determined by age- and sex-specific cutoffs for weight, KISHx, family history (FmHx) of end-stage knee OA, presence of bilateral Heberden’s nodes, frequent knee bending, and knee symptoms in the past 12 months. Outcomes were obtained from self-report questionnaires, including: knee function via the WOMAC Physical Function score and symptom management strategies, i.e. activity limitation due to knee symptoms in the past 30 days (yes/no), use of medications in the past year due to knee symptoms (yes/no). To assess the associations of the risk factors with each outcome, we used a general linear model and logistic regression to calculate effect estimates/odds ratios with 95% confidence intervals (CI). Analyses were stratified by knee pain frequency and adjusted for potential confounders.

Results: Of the analytic sample (n=2987, age 61.1 ± 9.3 years old, 59% female, BMI 28.3 ± 4.7 kg/m2), 988 were OW/OB, 1475 had KISHx, 500 reported knee OA FmHx, 755 had bilateral Heberden’s nodes, and 2182 reported frequent knee bending. Regardless of frequency of knee pain, those who were OW/OB or with KISHx had significantly worse knee function than those without each risk factor (Table). In those with infrequent knee pain, KISHx was associated with use of both symptom management strategies, while FmHx was only associated with activity limitation and presence of bilateral Heberden’s nodes was only associated with use of medications.  In individuals with frequent knee pain, OW/OB and KISHx were associated with use of both symptom management strategies.

Conclusion: KISHx and OW/OB were consistently associated with worse knee function regardless of the presence and frequency of knee pain. KISHx was also consistently associated with use of knee symptom management strategies when any knee pain was present, yet OW/OB was only associated in the presence of frequent knee pain. Other risk factors were not independently related to knee function, and inconsistently related to symptom management. These results emphasize the two most common risk factors for knee OA, OW/OB and KISHx, are also the most strongly related to knee function and symptom management. Early monitoring of people with these risk factors may allow for early intervention when symptoms present and delay the consequences of knee OA.

Table: Associations of risk factors with knee function and symptom management strategies, stratified by frequency of knee pain


Disclosure: J. Jakiela, None; D. White, None; H. Master, None; M. Christiansen, None; D. Voinier, None; L. Neely, None; L. Thoma, None.

To cite this abstract in AMA style:

Jakiela J, White D, Master H, Christiansen M, Voinier D, Neely L, Thoma L. Understanding Knee Function and Symptom Management in Individuals with Risk Factors for Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/understanding-knee-function-and-symptom-management-in-individuals-with-risk-factors-for-knee-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/understanding-knee-function-and-symptom-management-in-individuals-with-risk-factors-for-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology